WNT5A and melanoma: Consequently, knockdown of WNT5A signaling via siRNA treatment in BRAFi-resistant A375 melanoma cells led to a significant decrease in phospho-AKT (active form) in a PI3K-dependent manner, suggesting that WNT5A regulates PI3K-AKT in melanoma [101].